Financial News

First patient dosed in startup's key Covid-19 clinical trial

Airway Therapeutics has logged another key milestone in its path toward commercialization. The 10-year-old company, which is developing new interventions for acute and chronic lung diseases, dosed its first patient in a new clinical trial aimed at patients severely impacted by Covid-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback